Fate Therapeutics, Inc. · NASDAQ:FATE
Epstein Robert S exercised options for 25,000 Fate Therapeutics, Inc. shares (Form 4)
Traded May 5, 2026 · Filed May 6, 2026
On May 5, 2026, Epstein Robert S (Director) exercised options for 25,000 Fate Therapeutics, Inc. shares at US$1.69 for US$42,250, leaving 36,331 shares. Filed May 6, 2026 (Form 4).
- Options exercised
- 25,000 shares
- Price
- US$1.69
- Value
- US$42,250
- Holding after
- 36,331 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Option exercise | 25,000 | US$1.69 | 36,331 | Direct |